Comprised of leading global MS scientists and experts, including three people affected by MS, the Scientific Steering Committee sets priorities and develops plans to accelerate treatment development.

It achieves results by funding transformational research, convening scientific summits to share knowledge and stimulate discovery and collaborating with regulatory bodies, scientific leaders in other diseases and pharmaceutical experts.

Chair

Alan Thompson, UCL Pro Vice-Provost for London, Dean of the UCL Faculty of Brain Sciences, and Chair of the Neuroscience Programme for UCLP Academic Health Science Centre, University College London, (UK)

Vice-Chair

Bob Fox, Professor of Neurology, Cleveland Clinic Lerner College of Medicine, Staff Neurologist, Vice-Chair of Research, Neurological Institute, Cleveland Clinic, Cleveland Clinic, (US)

Members

Bruce Bebo, Executive Vice President, Research Programs, National MS Society, (US)
Giampaolo Brichetto, Coordinator, Research in rehabilitation, AISM — Italian MS Society, (IT)
Bill Carroll, Clinical Professor of Neurology, Consultant Neurologist, Neurologist, University of Western Australia, Perron Institute, Sir Charles Gairdner Hospital, (AU)
Olga Ciccarelli, Professor, Neurology at Queen Square Insititute of Neurology, University College London, (UK)
Tim Coetzee, Chief Advocacy, Services, and Research Officer, National MS Society, (US)
Giancarlo Comi, Professor of Neurology, Chairman of the Department of Neurology and Director of the Institute of Experimental Neurology, Vita-Salute San Raffaele University, Scientific Institute San Raffaele, (IT)
Gabriele Dati, Coordinator, Biomedical Research and Grant Office, AISM — Italian MS Society, (IT)
Alexis Donnelly, Person affected by MS, (IE)
Anthony Feinstein, Professor of Psychiatry, University of Toronto, (CA)
Emma Gray, Head of Clinical Trials, UK MS Society, (UK)
Anne Helme, Head of Research and Access, MS International Federation, (UK)
Reinhard Hohlfeld, Professor, Institute of Clinical Neuroimmunology, Munich University Hospital, (DE)
Pamela Kanellis, Assistant Vice President, Research, MS Society, Canada, (CA)
Doug Landsman, Vice President, Global Research, National MS Society, (US)
Catherine Lubetzki, Professor of Neurology, Head of the department of Neurological Diseases, Pierre and Marie Curie University, Salpêtrière Hospital, (FR)
Ruth Ann Marrie, Professor of Medicine and Community Health Sciences at the University of Manitoba and Director of the Multiple Sclerosis Clinic at Health Sciences Centre Winnipeg, University of Manitoba, (CA)
Xavier Montalban, Professor, Chairman & Director, Neurology-Neuroimmunology Department, Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d’Hebron Barcelona Hospital, (ES)
Julia Morahan, Head of Research, MS Australia, (AU)
Marco Salvetti, Director of the Center for Neurology and Experimental Therapies, La Sapienza University, Rome, (IT)
Finn Thorup Sellebjerg, Professor, Chief Physician, Department of Neurology, Head, MS center, University of Copenhagen, Danish Multiple Sclerosis Center, Rigshospitalet, (DK)
Caroline Sincock, Person affected by MS, (UK)
Kathy Smith, Consultant, International Progressive MS Alliance, (US)
Jon Strum, Person affected by MS, (US)
Clare Walton, Head of Research, MS Society, (UK)
Kathy Zackowski, Sr. Director, Patient Management, National MS Society, (US)
Paola Zaratin, Director of Scientific Research, AISM — Italian MS Society, (IT)

Join Us.

Together we are stronger than progressive MS.

Join Us.